SELLAS LIFE SCIENCES REACHES 80TH EVENT IN PHASE 3 REGAL TRIAL OF GALINPEPIMUT-S (GPS) IN ACUTE MYELOID LEUKEMIA

Reuters · 5d ago

Please log in to view news